Advances in Multiple Sclerosis and Experimental Demyelinating Diseases (Paperback, 2008 ed.)

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.

General

Imprint:	Springer-Verlag
Country of origin:	Germany
Series:	Current Topics in Microbiology and Immunology, 318
Release date:	September 2014
First published:	2008
Editors:	Moses Rodriguez
Dimensions:	235 x 155 x 20mm (L x W x T)
Format:	Paperback
Pages:	362
Edition:	2008 ed.
ISBN-13:	978-3-642-43783-0
Categories:	Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN:	3-642-43783-4
Barcode:	9783642437830

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!